Sphera Funds Management Ltd. Sage Therapeutics, Inc. Put Options Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $2.19 Million - $4.01 Million	-24,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $2.01 Million - $3.42 Million	24,500 New	24,500 $2.35 Million
Q1 2018 May 10, 2018	SELL	$152.15 - $192.33 $365,160 - $461,592	-2,400 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$61.4 - $88.52 $147,360 - $212,448	2,400	2,400 $150,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.